Synthesis and Characterization of Low Cytotoxicity Polyvinylamine (PVAm)-Based Cationic Polymers

Area of Science:

• Polymer Chemistry
• Biomaterials Science
• Nanotechnology

Background:

• Cationic polymers are essential synthetic vectors for nucleic acid delivery due to strong electrostatic interactions.
• Polyvinylamine (PVAm) is a highly cationic polymer but exhibits significant cytotoxicity owing to its dense positive charge.
• Chemical modifications are needed to reduce PVAm's cytotoxicity for safe in vivo applications.

Purpose of the Study:

• To investigate the impact of chemical modifications on PVAm's cytotoxicity.
• To explore how different tail structures (saturated, unsaturated, multi-tails, hydrogen-bonded) influence cell toxicity.
• To assess the potential of PVAm-based polymers, formulated as mixed micelles with Kolliphor P188, for reduced cytotoxicity in nucleic acid delivery.

Main Methods:

• Chemical modification of the PVAm backbone via epoxide ring-opening, amine-carboxylic acid coupling, and amine-ketone reactions.
• Grafting of hydrophobic chains onto PVAm to create PVAm-based cationic polymers.
• Formation of mixed micelles between modified PVAm and Kolliphor P188.
• Evaluation of cell cytotoxicity based on structural modifications and tail characteristics.

Main Results:

• Chemical modifications effectively reduce the cytotoxicity of PVAm by altering polyplex internal order.
• The nature of grafted tails (saturated, unsaturated, multi-tails, hydrogen-bonded) influences the degree of cytotoxicity reduction.
• PVAm-Kolliphor P188 mixed micelles demonstrate reduced interaction with cell membranes, mitigating toxicity.
• Hydrophobic chain grafting shields the positive surface charge, minimizing nonspecific electrostatic interactions.

Conclusions:

• Tailoring PVAm's chemical structure and incorporating hydrophobic chains are effective strategies to decrease cytotoxicity.
• Modified PVAm-based polymers offer a promising platform for developing safer nucleic acid delivery systems.
• Further research into structure-toxicity relationships can guide the design of advanced biomaterials for gene therapy.